Awakening the Sleeping Giant: How Biological Agents Reactivate Epstein Barr Virus and What You Can Do About It Dr. Jill Carnahan, MD An Unusual Case of Acute Epstein Barr Virus Hepatitis Presenting as Severe Cholestatic Liver Disease Inducing Hemophagocytic Lymphohistiocytosis in a Young Adult: A Case Report Cureus Frontiers Exploring common pathogenic association between Epstein Barr virus infection and long COVID by integrating RNA Seq and molecular dynamics simulations TNF inhibits Epstein Barr virus reactivation through the GPX4 mediated glutathione pathway Scientific Reports Epstein Barr virus transformed B cells from a hypoxia model of the germinal center requires external unsaturated fatty acids PLOS Pathogens